title: Hypoprothrombinemia from coadministration of sulofenur (LY 186641) and warfarin: report of three cases.
authors.affiliation: Department of Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston 77030.
authors.forename: F V
authors.initials: FV
authors.lastname: Fossella
authors.forename: S M
authors.initials: SM
authors.lastname: Lippman
authors.forename: D E
authors.initials: DE
authors.lastname: Seitz
authors.forename: D S
authors.initials: DS
authors.lastname: Alberts
authors.forename: C W
authors.initials: CW
authors.lastname: Taylor
authors.forename: E
authors.initials: E
authors.lastname: Wiltshaw
authors.forename: J
authors.initials: J
authors.lastname: Hardy
authors.forename: M
authors.initials: M
authors.lastname: O'Brien
authors.forename: T R
authors.initials: TR
authors.lastname: Haynes
authors.forename: R L
authors.initials: RL
authors.lastname: Wolen
mesh_terms: D000230:Adenocarcinoma / Q000097:blood / Q000188:drug therapy* / Q000556:secondary; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D004341:Drug Evaluation; D004347:Drug Interactions; D005260:Female; D006801:Humans; D007020:Hypoprothrombinemias / Q000139:chemically induced*; D008175:Lung Neoplasms / Q000097:blood / Q000188:drug therapy*; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000097:blood / Q000188:drug therapy*; D013453:Sulfonylurea Compounds / Q000008:administration & dosage*; D014859:Warfarin / Q000008:administration & dosage*
chemical_list: D013453:Sulfonylurea Compounds; D014859:Warfarin; C058179:sulofenur